Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (103)

21

Virology analysis in HCV genotype 1-infected patients treated with the combination of simeprevir and TMC647055/ritonavir, with and without ribavirin, and JNJ-56914845

enthalten in: Virology journal | 2017

von Vijgen, L. | Thys, K. | Vandebosch, A. | +3

22

Virology analysis in HCV genotype 1-infected patients treated with the combination of simeprevir and TMC647055/ritonavir, with and without ribavirin, and JNJ-56914845

enthalten in: Virology journal | 2017

von Vijgen, L. | Thys, K. | Vandebosch, A. | +3

23

Virology analysis in HCV genotype 1-infected patients treated with the combination of simeprevir and TMC647055/ritonavir, with and without ribavirin, and JNJ-56914845

enthalten in: Virology journal | 2017

von Vijgen, L. | Thys, K. | Vandebosch, A. | +3

24

Deep sequencing analysis of HIV-1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase III studies ECHO and THRIVE

enthalten in: Journal of medical virology | 2016

von Van Eygen, V. | Thys, K. | Van Hove, C. | +5

25

Pre-existence and Persistence of Resistant Minority Hepatitis C Virus Variants in Genotype 1-Infected Patients Treated With Simeprevir/Peginterferon/Ribavirin

enthalten in: Open forum infectious diseases | 2016

von Fevery, B. | Thys, K. | Van Eygen, V. | +8

26

Assessment of etravirine resistance in HIV-1-infected paediatric patients using population and deep sequencing : final results of the PIANO study

enthalten in: Antiviral therapy | 2016

von Tambuyzer, L. | Thys, K. | Hoogstoel, A. | +5

27

Deep sequencing analysis of HIV‐1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase III studies ECHO and THRIVE

enthalten in: Journal of medical virology | 2016

von Van Eygen, V. | Thys, K. | Van Hove, C. | +5

28

In Vitro Activity of Simeprevir against Hepatitis C Virus Genotype 1 Clinical Isolates and Its Correlation with NS3 Sequence and Site-Directed Mutants

enthalten in: Antimicrobial agents and chemotherapy | 2015

von Verbinnen, T. | Fevery, B. | Vijgen, L. | +3

29

Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevir

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2015

von Fevery, B. | Susser, S. | Lenz, O. | +7

30

Trends in darunavir resistance-associated mutations and phenotypic resistance in commercially tested United States clinical samples between 2006 and 2012

enthalten in: AIDS research and human retroviruses | 2015

von Lathouwers, E. | Gupta, S. | Haddad, M. | +3